Here, we publish important new scientific research and materials, discuss significant NGP category developments in the media, report on scientific conferences we’ve attended, and more. Please note not all of this content is available in certain territories.
TWO NEW PIECES OF IN-VITRO TESTING CONDUCTED BY IMPERIAL BRANDS SCIENCE PRESENT FURTHER EVIDENCE OF HEATED TOBACCO’S HARM REDUCTION POTENTIAL COMPARED TO COMBUSTIBLE CIGARETTE SMOKING. MATTHEW STEVENSON, INVESTIGATIVE AND MECHANISTIC TOXICOLOGY SENIOR MANAGER, EXPLAINS. Pulze is our innovative heated tobacco (HT) device which heats – but doesn’t burn – a portion of reconstituted tobacco contained […]
28 Oct 2021
IMPERIAL BRANDS IS PRESENTING A NUMBER OF EXCITING RESEARCH PROJECTS AT THIS YEAR’S CORESTA CONGRESS AS PART OF OUR ONGOING SCIENTIFIC SUBSTANTIATION OF OUR NEXT GENERATION PRODUCT PORTFOLIO… CORESTA (Cooperation Centre for Scientific Research Relative to Tobacco) promotes international cooperation in scientific research relating to tobacco and Next Generation Products (NGPs). As a longstanding member […]
11 Oct 2021
Any viable less harmful alternatives to cigarettes must be acceptable to those adult smokers who would otherwise continue to smoke, but should not appeal to non-smokers. This infographic blog explores a key pre-market study assessing perceptions and intentions to use Imperial’s heated tobacco device, Pulze, Dr Thomas Nahde, Head of Scientific and Regulatory Affairs (DACH […]
7 Oct 2021
Last week, the Global Tobacco & Nicotine Forum (GTNF) took place in London. The annual event provides a platform for debate and the exchange of ideas around tobacco, Next Generation Products (NGPs) and nicotine among public health experts, industry representatives and other key stakeholders. This year, Imperial Brands CEO Stefan Bomhard presented a keynote in […]
28 Sep 2021
As the comprehensive evidence-base substantiating heated tobacco builds, so does the number of endorsements from public health bodies, recognising the category’s dramatic harm reduction potential. Explore the timeline below to see some of its major milestones … One of the most promising tobacco harm reduction (THR) innovations for adult smokers who would otherwise continue to […]
15 Sep 2021
Chairing the 74th Tobacco Science and Research Conference, Group Science and Regulatory Affairs Director Joe Thompson shares some thoughts from his keynote address. It’s with great pleasure that I’m chairing the 74th Tobacco Science and Research Conference (TSRC), a hybrid event taking place both virtually and in Boston, Massachusetts, US. Boston, of course, is […]
31 Aug 2021
